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Paracetamol is a medicine compound commonly used as analgesic and antipyretic.1-5 
It is classified as one of the drugs, known as aniline analgesics.6-9 It is used widely for 
the relief of a headache, other minor aches, pains, inflammations and a major 
ingredient in several cold and flu remedial combination drugs. While generally safe 
for use at a recommended dose, toxicity of paracetamol is the foremost cause of acute 
gastro intestinal problems.10-12 Paracetamol is considered to be the inhibitor of 
cyclooxygenase (COX), and recent reports suggest that it is highly selective for COX-
2. While it has analgesic and antipyretic properties comparable to those of aspirin or 
other NSAIDs, its peripheral anti-inflammatory activity is usually limited by several 
factors, one of which is high level of peroxides present in inflammatory lesions. It 
could be considered as one of Non-Steroidal Anti Inflammatory Drugs (NSAID).13-20 
Many methods for its determination have been described in literature, including 
chromatography (RP - HPLC), chemometric - assisted spectrophotometric 
spectroscopy, Spectrophotometry and electrochemistry. 
Many spectrophotometric methods required complicated treatment, such as long 
period of heating (60-90 min) using concentrated acids as hydrolysis reagent. This 
work based on the oxidation of paracetamol by using Cr(VI) in presence of 6M 
sulfuric acid and 15 min heating at 80 °C as shown in scheme 1. 
Results: 
In this method, paracetamol is deacetylated to p-aminophenol in the first step, then 
oxidised by potassium dichromate to benzoquinone (scheme 1), and the absorbance of 
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the chromium (IV) species produced at 580 nm, is the measure of paracetamol 
concentration. 
Paracetamol was prepared in the laboratory by a method described by vogel.21 The 
material was checked by melting point and found within the recorded rang (168-
172 °C) and used as a stock material. Then 13 different medicines contain 
paracetamol as the main ingredient were collected from different pharmacies around 
the city of Zliten, and taken under the study to measure paracetamol concentration in 
them.  
             
 
Scheme 1 shows the steps of paracetamol oxidation 
Table 1 shows the concentrations of paracetamol in the 13 medicines which supplied 
by different companies compared with the pure paracetamol.  
From that table, it can be seen that some of medicine have paracetamol within the 
right concentration (2-5). While some drugs contain higher concentration than what it 
is included in their leaflet (13, 14) and some have lower than the provided amounts. 
Discussions: 
The excess or the lack of acetaminophen contents obtained in the spectrophotometric 
results using by this method may be due to the effect of interference i.e. the excipients 
used in formulation. Any ingredients added to paracetamol formulation contain 
aromatic amine, it is likely to interfere with the determination of active in the 
paracetamol tablet. The commonly used preservatives in the formulation of 
paracetamol in most of the pharmaceutical companies in Nigeria are methyl and 
propyl paraben. Other additives may include Talcum powder to give shining and 
smoothness to the tablet, starch as binding agent, magnesium stearate as lubricant, 
gelatine and lactose. 
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 Drug Form Commercial name Supplier Paracetamol 
found (mg) 
Error 
1 Paracetamol (100 mg) Powder - Lab made 100 - 
2 Paracetamol (500 mg) Tablet Paracetamol England 100.6 +0.6 
3 Paracetamol (500 mg) + caffeine 65 mg Tablet Paracetamol with caffeine England 495 -5 
4 Paracetamol (500 mg) Effervescent tablet Paracetamol IPS Tunisia 490 -10 
5 Paracetamol (500 mg) Effervescent tablet Doliprane Germany 483 -17 
6 Paracetamol (500 mg) Effervescent tablet Doliprane Tunisia 477 -23 
7 Paracetamol (400 mg) + Ascorbic acid (300 mg) + 
Ibuprofen (200 mg) + Caffeine (25 mg) 
Powder Rhumix Marroco 375 -25 
8 Paracetamol (325 mg) tablet Really Extra India 254 -46 
9 Paracetamol (325 mg), Ibuprofen (200 mg) Tablet Megafen Egypt 224 -101 
10 Paracetamol (500 mg) Tablet Cetamol Tunisia 312 -188 
11 Paracetamol (500 mg) Tablet Panadol Tunisia 300 -200 
12 Orphendrine Citrate 35 mg Tablet Muscadol UEA 197 -303 
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13 Paracetamol 450 mg + Orphendrine Citrate 35 mg Tablet Norgesic Egypt 645 +195 
14 Paracetamol (500 mg) Tablet Adol UEA 763.5 +263.5 
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This work shows that the low or high values of paracetamol concentrations in 
pharmaceuticals compared to the expected values could be due to poor drug control, 
as well as the state of chaos in the country and its consequent smuggling and mis-
storage, which leads to rapid spread among patients due to cheap prices and thus do 





A JENWAY- SPEC/6400, 520 ×330 × 180 mm :Rs 232 output, band width of 5 nm 
Scanning Visible Spectrophotometer with recording unit and matched a set of 1 cm. 
glass or quartz cuvettes were used for recording the spectra. All the weighing 
measurements were made by a Shimadzu-AUX-220 model digital electronic balance. 
Reagents: 
Stock solutions were made from commercially available analytical or pharmaceutical 
grade chemicals and high purity distilled water. Working solutions were prepared by 
appropriate dilution of the stock solutions. The 0.135M potassium dichromate 
solution was prepared in 12M sulphuric acid. 
Paracetamol solutions (1 mg/ml) were also prepared from pharmaceutical-grade 
tablets and capsules. The pure stock solution was prepared by dissolving exactly 
0.500 g in about 150 ml of warm water, stirring for10 min and diluting to volume in a 
500-ml standard flask after cooling. 
General procedure: 
Place 10 ml of potassium dichromate stock solution in a 50-ml standard flask. Add 
15.0 ml of 6M sulphuric acid and the appropriate amount of paracetamol solution. 
Swirl the flask and its contents and dilute to the mark. Place the flask in a water-bath 
maintained at 80” and leave it there for15 min. Cool under tap water, and measure the 
absorbance at 580 nm against a reagent blank treated similarly. 
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